ANEB
ANEB
NASDAQ · Pharmaceuticals

Anebulo Pharmaceuticals Inc

$1.03
+0.01 (+0.98%)
As of Mar 25, 5:20 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +4,753.4% upside
Low Target $34.23
Average Target $49.99
High Target $60.95
Current Price $1.03
Current
$1.03
Target
$49.99
$34.23 $49.99 avg $60.95
Scenario Analysis
Bear Case
$34.23
3,223.3%
Low target
Base Case
$49.99
+4,753.4%
Avg target
Bull Case
$60.95
+5,817.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.42
-69.9% from high
52-Week Low
$0.30
+243.4% from low
Target vs 52W High
$49.99
+1,361.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%